Bessemer Group
SYRS

Bessemer Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bessemer Group’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,490
Closed -$585K – 1716
2020
Q2 		$585K Buy
+5,490
New +$585K ﹤0.01% 927